U.S. Manufacturing Outlook Much Sunnier for 2011, PwC Says
01/28/2011
"The major shift from uncertainty to optimism in this quarter's findings gives us good reason to be hopeful. We may now begin to see industrial manufacturers start making business decisions in a less guarded, more confident manner as we move into 2011," said Barry Misthal, U.S. industrial manufacturing leader for PwC. "The industry is looking quite strong and steady compared with the past couple of years, and manufacturers appear poised for a robust start to the new year."
In the fourth quarter of 2010, 61 percent of panelists said the U.S. economy was growing, a 34 point rise from the third quarter.
Nearly half of those surveyed said they planned to hire workers this year, an increase of six points from the third quarter of 2010. Eighty-two percent plan to increase operational spending. Nearly a third are planning new facilities, and expansion plans are also on the rise.
The most significant impediment to this growth remains legislative and regulatory pressures. Manufacturers were also concerned about tax policies as a barrier to growth.
Project Announcements
Walmart Upgrades Opelousas, Louisiana, Distribution Operations
01/20/2026
Canada-Based Voltari Marine Electric Plans Bay County, Florida, Operations
01/20/2026
Japan-Based DENSO Expands Lebanon, Tennessee, Logistics Operations
01/20/2026
Infinity Global Expands Danville, Virginia, Headquarters Operations
01/17/2026
Kratos Plans Somerset County, Maryland, Production Operations
01/17/2026
CesiumAstro Expands Bee Cave, Texas, Headquarters-Manufacturing Operations
01/16/2026
Most Read
-
The Workforce Bottleneck in America’s Manufacturing Revival
Q4 2025
-
Data Centers in 2025: When Power Became the Gatekeeper
Q4 2025
-
Speed Built In—The Real Differentiator for 2026 Site Selection Projects
Q1 2026
-
Preparing for the Next USMCA Shake-Up
Q4 2025
-
Tariff Shockwaves Hit the Industrial Sector
Q4 2025
-
Investors Seek Shelter in Food-Focused Real Estate
Q3 2025
-
The New Industrial Revolution in Biotech
Q4 2025